Key result
Hypereosinophilic syndrome shows sequential cardiac progression from thrombotic to fibrotic stages over 4 years.
Why the study?
Definitive evidence that patients with hypereosinophilic syndrome sequentially pass through the acute necrotic, thrombotic, and fibrotic cardiac stages is lacking.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case report provides evidence that cardiac involvement in hypereosinophilic syndrome can progress sequentially from the thrombotic stage to the fibrotic stage.
Cardiac involvement is a major cause of morbidity and mortality in hypereosinophilic syndrome (HES). It is classified into 3 stages by the degree of eosinophils-mediated heart injury; acute necrotic stage, thrombotic stage, and fibrotic stage. Nonetheless, definitive evidence that each patient passes sequentially through these stages is lacking. We present a case of 48-year-old male patient with dyspnea and peripheral edema who underwent valve replacement surgery due to severe mitral regurgitation. After the valve replacement, HES with cardiac involvement in the thrombotic stage was diagnosed. In the follow-up study, the patient progressed into fibrotic stage of HES.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2015) conducted a case report in Hypereosinophilic syndrome with cardiac involvement (n=1). Hypereosinophilic syndrome was evaluated on Cardiac involvement progression. Hypereosinophilic syndrome with cardiac involvement demonstrated sequential progression from the thrombotic stage to the fibrotic stage over a 4-year follow-up period.
Synapse has enriched 10 related papers. Consider them for comparative context: